SCHEMBL7993133

SCHEMBL7993133

NS(=O)(=O)c1ccc2c(c1)CC=C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 15/20 0.50
CA1 P00915 14/20 0.50
CA12 O43570 10/20 0.50
CA7 P43166 7/20 0.50
CA14 Q9ULX7 7/20 0.50
CA9 Q16790 11/20 0.45
ADRA2A P08913 1/20 0.44
PNMT P11086 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
CA4 P22748 4/20 0.40
CA6 P23280 4/20 0.40
CA5A P35218 4/20 0.40
CA5B Q9Y2D0 4/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30232448 0.85 CA2 (0.50) CA2CA1CA12CA7CA14
SCHEMBL4239331 0.85 CA2 (0.50) CA2CA1CA12CA7CA14
SCHEMBL27675520 0.84 CA2 (0.49) CA2CA1CA12CA7CA14
SCHEMBL27052187 0.81 CA1 (0.46) CA2CA1CA12CA7CA14
SCHEMBL30311540 0.81 CA1 (0.46) CA2CA1CA12CA7CA14
SCHEMBL17771331 0.78 CA12 (0.41) CA2CA1CA12CA7CA14
Benzenesulfonamide SCHEMBL27317322 0.75 CA2 (0.55) CA2CA1CA12CA7CA14
SCHEMBL30232425 0.74 CA1 (0.46) CA2CA1CA12CA7CA14
SCHEMBL8353563 0.71 CA2 (0.51) CA2CA1CA12CA7CA14
SCHEMBL9079118 0.71 CA1 (0.44) CA2CA1CA12CA7CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281240-B1 CYSTIC FIBROSIS ELI LILLY AND COMPANY 2001-08-28 US disclosed
WO-1998044799-A1 DIARYLSULFONYLUREAS FOR USE IN TREATING SECRETORY DIARRHEA ELI LILLY AND COMPANY (US) 1998-10-15 WO disclosed
EP-0606723-A1 Imidazolidin-2-one derivatives and their use as antitumor agents ELI LILLY AND COMPANY (US) 1994-07-20 EP disclosed
US-5270329-A 1-arylsulfonyl-imidazolidin-2-one derivatives ELI LILLY AND COMPANY (US) 1993-12-14 US disclosed
US-5262440-A Treatment of neoplasms ELI LILLY AND COMPANY (US) 1993-11-16 US disclosed
EP-0546763-A1 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1993-06-16 EP disclosed